Target intelligence / Profile preview

RNA, U6atac small nuclear 34, pseudogene (RNU6ATAC34P)

Target
RNU6ATAC34P
Molecular classification
Pseudogene, Small nuclear RNA pseudogene, Non-coding RNA pseudogene
01

Overview

RNU6ATAC34P (RNA, U6atac small nuclear 34, pseudogene) is a non-coding, nonfunctional pseudogene related to the U6atac small nuclear RNA gene family; it does not encode for a functional snRNA and does not participate in splicing or any cellular pathway. U6atac snRNAs are normally components of the minor (U12-type) spliceosome, required for the splicing of a rare class of pre-mRNA introns ("AT-AC" or U12-type introns)[1][2]. Pseudogenes in this family, such as RNU6ATAC34P, are likely generated via retrotransposition events, lack upstream promoter elements, are not transcribed into functional snRNA, and have no known functional or clinical significance[1][2]. They serve as molecular fossils within the genome, not encoding protein or acting as therapeutic targets. Note: This entry is not a therapeutic target or functionally active gene and should not be studied as a receptor, enzyme, transporter, or other classic target class. It is a non-functional pseudogene and does not fit the molecular or clinical definition of a druggable target[1][2]. If functional information on the active U6atac snRNA (not the pseudogene) is required, that would refer to the actual *RNU6ATAC* gene, not RNU6ATAC34P[3][4].

Other names
RNU6ATAC34PU6atac-34 pseudogene
02

Mechanism of action

None (drugs do not target pseudogenes, as they lack active function)

03

Biological functions

None (this particular pseudogene does not have a functional biological role)
04

Disease associations

None known (no established link to disease; not implicated in pathology)
05

Safety considerations

None (no therapeutic relevance or intervention risk)
06

Interacting drugs

None (no RNA, protein, or enzyme product to act as a drug target)
07

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on RNA, U6atac small nuclear 34, pseudogene (RNU6ATAC34P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6atac small nuclear 34, pseudogene (RNU6ATAC34P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call